AstraZeneca Reports Q3 Results Beat, Launches $1.5 Billion Annual Savings Plan
AstraZeneca shares rise after Q3 results beat; the company launched an annual savings plan worth $1.5 billion.
AstraZeneca shares rise after Q3 results beat; the company launched an annual savings plan worth $1.5 billion.